Navigation Links
Toxic Neglect: Mutual Funds Opposing Shareholder Resolutions on Chemicals in Products Ignore Financial Risks to Shareholders
Date:2/28/2008

Turning a Blind Eye to Risk: Fidelity, American Funds, T Rowe Price, ING, Morgan Stanley, MassMutual; Some Encouraging Signs Seen at TIAA-CREF and ISS

WASHINGTON, Feb. 28 /PRNewswire/ -- More than three out of four major mutual fund families in the United States -- 40 out of 52 (or 77 percent) -- routinely opposed or abstained from voting on toxic chemical shareholder resolutions in 2006 and 2007, according to a major new report today from The Investor Environmental Health Network (IEHN) and The Rose Foundation for Communities and the Environment.

The IEHN/Rose report, Mutual Neglect: How the Largest Institutions in the Stock Market Ignore Health Problems and Financial Threats Stemming From Toxic Product Liabilities draws on data from a total of 64 families of mutual funds casting votes in 2006 and 2007 on shareholder resolutions. Only 195 votes were cast in favor and 1,752 were cast against shareholder resolutions addressing issues such as pesticides and asthma and toxic chemicals in children's toys and cosmetics. Entire fund families such as ING (213 "no" votes), Morgan Stanley (90 "no" votes), and T Rowe Price (110 "no" votes) voted against ALL resolutions. Fidelity and American Funds also did not support any resolutions. Vanguard abstained 157 times, maintaining that "social policy issues" such as toxic chemicals in products are "ordinary business" best handled by company management.

Ironically, the report finds that funds of two financial companies that market both mutual funds and health insurance -- John Hancock and MassMutual -- did not support resolutions at Dow Chemical Company requesting an assessment of links between the company's pesticide products and asthma. Morgan Stanley's mutual funds also voted against this resolution, even though Morgan Stanley contributed $60 million to the Morgan Stanley Children's Hospital in 2003, whose services include a facility to treat childhood asthma.

Tim Little, executive director, The Rose Foundation and a contributor to the report said: "Even as more and more evidence mounts of the danger posed to the public's health and the wealth of shareholders by toxic chemicals in products, America's largest fund families are continuing to turn a blind eye to the problem. The only problem for shareholders here is that denial is no investment strategy. When it comes to mutual funds investing in companies with toxic products, denial is inevitably going to be a prescription for financial disaster."

Richard Liroff, executive director of IEHN, commented: "Mutual fund investors are really shareholder/consumers. Their investment gains may be offset by the costs they incur from chemicals in everyday products. So their return on investment may be lower or even negative, if one counts their health costs from exposures to chemicals in products made by their portfolio companies."

According to the report, toxic chemicals in products can have a sizeable business impact of the sort that hurts the bottom lines of mutual funds and their shareholders. Examples include recall costs, litigation expenses and a sharp stock price drop at Thomas the Tank Engine manufacturer RC2; reduced sales growth in beauty products at Procter & Gamble because of allegations in China of contaminated skin cream; litigation and civil penalty costs at DuPont over the PFOA used to manufacture Teflon coatings; and reputational damage at Wal-Mart and other retailers over recalled baby bibs and lunch boxes.

ENCOURAGING SIGNS AND RECOMMENDATIONS

Despite the predominately gloomy picture it paints, the report finds several reasons for hope.

-- First, are revisions to TIAA-CREF's proxy voting guidelines in 2007. The $430 billion fund family's new proxy voting guidelines section on "Product Responsibility" declares that TIAA-CREF will generally support reasonable shareholder resolutions seeking disclosure of the safety and impact of company products on customers and communities. TIAA-CREF funds supported all toxic chemical resolutions at their portfolio companies in 2007.

-- Second, are new proxy voting guidelines adopted by government employee pension funds in Connecticut, New York City, and Maryland that also address product stewardship issues.

-- Third, are recent revisions to the proxy voting guidelines of Institutional Shareholder Services, the largest proxy voting advisory service in the United States, recognizing the need for companies to better address toxic chemicals in their supply chains.

The report makes 3 recommendations to the mutual fund industry:

-- Adopt proxy voting guidelines similar to ISS or TIAA-CREF.

-- Follow TIAA-CREF's lead and survey their participants' opinions on responsible investing, including shareholder activism.

-- Fund trustees should explore issues of links between toxic chemicals and financial risk with their investment managers and consultants.

The report also urges investors in mutual funds to contact their funds' investor services department to ask that funds adopt proxy voting guidelines addressing these issues

Many mutual funds seem to be ignoring the business case behind shareholder resolutions seeking to reduce toxics in consumer products. What's worse, many mutual funds also seem to be voting against their shareholders' health. Funds that continue to turn a tin ear towards toxics may find themselves losing market share in the very competitive mutual fund marketplace.

For the full report, go to http://iehn.org/publications.reports.mutualfunds.php on the Web.

METHODOLOGY

IEHN's analysis of mutual fund voting draws on a database of voting behavior of 1,400 funds in 64 mutual fund families compiled by Jackie Cook of Boardmap Research, Vancouver, Canada. This is an extensive but not exhaustive database of more than 8.5 million voting decisions by most of the largest funds from most of the largest U.S. fund groups over four years. The data and data summaries are available on-line at:

http://www.fundvotes.com/IEHN/Toxics_FundVoteResults_2006-2007.xls.

ABOUT THE GROUPS

The Investor Environmental Health Network (http://www.iehn.org) is a collaboration of investment managers encouraging companies to adopt "safer chemicals" policies for products, to enhance shareholder value. IEHN participants manage more than $41 billion in assets.

The Rose Foundation for Communities and the Environment has been recognized nationally for innovative shareholder advocacy campaigns and for its research into the correlation between corporate environmental and financial performance. Its petition to the U.S. Securities and Exchange Commission seeking more robust disclosure of environmental risk has been endorsed by institutional investors collectively representing more than $1 trillion in assets under management.


'/>"/>
SOURCE Investor Evironmental Health Network (IEHN), Washington,D.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Federal toxics disclosure law could help inform public of nanotechnology risks
2. AAP Calls for an End to Toxic Tobacco Content in Hollywood Movies
3. U.S. Seeks to Limit Animal Testing of Toxic Chemicals
4. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
5. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
6. Wild Childs Quit Nits Offers a Safe, Natural Alternative to Current Toxic Head Lice Products
7. A promising new approach to cadmium induced hepatoxicity: Cytoprotective effect of midkine
8. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
9. Another smart cancer drug can have toxic effects on the heart
10. Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
11. ABA Conference in Chicago Provides Litigators First Look at DNA Technology That Can Save Millions in Workers Comp and Toxic Tort Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology: